Fin Health

General contacts
Investor type

PE / VC

Founded

-

AUM

-

Location

São Paulo, São Paulo, Brazil

Investment Ticket

$10-50 m

Investment Stage

Series A Seed Pre-seed Series B Late Stage (Series C+)

Region of investment

South America
Investor profile last updated: 14 August, 2026

Profile

FinHealth Gestão de Recursos Ltda is an investment manager specialized in Life Sciences and Health, with headquarters in Brazil. The firm focuses on early-stage and growth companies, aiming to provide consistent returns through highly competitive products and services. The team includes internationally trained professionals, with senior partners like Luis Claudio Garcia de Souza leading the financial services strategy and Marcio Garcia de Souza handling compliance and real estate strategies.

FinHealth invests in sectors such as healthcare services, diagnostic services, biopharmaceuticals for human and animal health, digital health, contract research organizations (CROs), and medical diagnostics equipment. They also explore innovative financial services initially targeted at the inefficiencies of large banking conglomerates, later embracing the disruptive potential of digitalization and data science in financial services. Known investments include companies focused on health and life sciences, but specific notable investments were not listed on their site.

The firm's approach includes being active participants in the companies they invest in, offering back-office services through a shared services center and committing professionals to the ventures to help focus on key business activities. The detailed list of portfolio companies was not provided in the available sources.

Industry

HealthTech Life Sciences Technology MedTech SaaS Infrastructure Pharmaceuticals Medical Devices Healthcare Services Fintech Financial Services Digital Consumer Services (B2C) Consumer Products Business Services (B2B)

Contacts

Name
Title
Email
Social Networks
avatar
Bryant E. Fong Partner, Saúde e Ciências da Vida
Partner, Saúde e Ciências da Vida
b•••@•••
LinkedIn
avatar
Rian Maia Private Equity & Venture Capital Analyst
Private Equity & Venture Capital Analyst
r•••@•••
LinkedIn
Upgrade to see contacts
avatar
TqoLB5mpzRyI7iMt TqoLB5mpzRyI7iMt
TqoLB5mpzRyI7iMt
[email protected]
linkedin twitter
avatar
TqoLB5mpzRyI7iMt TqoLB5mpzRyI7iMt
TqoLB5mpzRyI7iMt
[email protected]
linkedin twitter
avatar
TqoLB5mpzRyI7iMt TqoLB5mpzRyI7iMt
TqoLB5mpzRyI7iMt
[email protected]
linkedin twitter
Investment-team contacts for Fin Health — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Fin Health

Fin Health is a venture capital and private equity firm. It backs companies at Series A, Seed, Pre-seed, Series B and Late Stage (Series C+), writing tickets of $10-50 m.
Fin Health is located in São Paulo, São Paulo, Brazil.
Fin Health was founded in .
Fin Health invests in companies and startups in HealthTech, Life Sciences, Technology, MedTech, SaaS, Infrastructure, Pharmaceuticals, Medical Devices, Healthcare Services, Fintech, Financial Services, Digital, Consumer Services (B2C), Consumer Products, Business Services (B2B).
Fin Health invests in companies and startups in South America.
Fin Health invests in companies and startups at Series A, Seed, Pre-seed, Series B, Late Stage (Series C+).
Fin Health usually invests $10-50 m on average.
Fin Health can be reached through its website finhealth.com.br and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Fin Health — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Fin Health directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 14 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.